nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM5—GPCR downstream signaling—CXCR2—periodontitis	0.00198	0.00198	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL3—periodontitis	0.00197	0.00197	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL3—periodontitis	0.00196	0.00196	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—NOS2—periodontitis	0.00196	0.00196	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL3—periodontitis	0.00196	0.00196	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL3—periodontitis	0.00194	0.00194	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CCR2—periodontitis	0.00192	0.00192	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CCR2—periodontitis	0.00192	0.00192	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—ADRB1—periodontitis	0.00192	0.00192	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CCR2—periodontitis	0.00191	0.00191	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—ADRB1—periodontitis	0.00191	0.00191	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—ADRB1—periodontitis	0.0019	0.0019	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CCR2—periodontitis	0.00189	0.00189	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—ADRB1—periodontitis	0.00188	0.00188	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCR2—periodontitis	0.00188	0.00188	CbGpPWpGaD
Brompheniramine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00184	0.00184	CbGpPWpGaD
Brompheniramine—CHRM4—G alpha (i) signalling events—CXCL8—periodontitis	0.00183	0.00183	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—SLC52A3—periodontitis	0.00183	0.00183	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCR2—periodontitis	0.0018	0.0018	CbGpPWpGaD
Brompheniramine—KCNH2—SIDS Susceptibility Pathways—IL6—periodontitis	0.00178	0.00178	CbGpPWpGaD
Brompheniramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00176	0.00176	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL3—periodontitis	0.00172	0.00172	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00169	0.00169	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL3—periodontitis	0.00165	0.00165	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00162	0.00162	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CCR2—periodontitis	0.00161	0.00161	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—ADRB1—periodontitis	0.0016	0.0016	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—SLC52A3—periodontitis	0.00157	0.00157	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—VIP—periodontitis	0.00157	0.00157	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—VIP—periodontitis	0.00156	0.00156	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—VIP—periodontitis	0.00156	0.00156	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—VIP—periodontitis	0.00154	0.00154	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CCR2—periodontitis	0.00154	0.00154	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—SLC52A3—periodontitis	0.00154	0.00154	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—ADRB1—periodontitis	0.00153	0.00153	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CCR2—periodontitis	0.00146	0.00146	CbGpPWpGaD
Brompheniramine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00146	0.00146	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—ADRB1—periodontitis	0.00145	0.00145	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—VIP—periodontitis	0.00142	0.00142	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—VIP—periodontitis	0.00142	0.00142	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—VIP—periodontitis	0.00142	0.00142	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—VIP—periodontitis	0.0014	0.0014	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—CCL2—periodontitis	0.0014	0.0014	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCR2—periodontitis	0.0014	0.0014	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CCR2—periodontitis	0.0014	0.0014	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCR2—periodontitis	0.00139	0.00139	CbGpPWpGaD
Brompheniramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00139	0.00139	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—ADRB1—periodontitis	0.00139	0.00139	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCR2—periodontitis	0.00139	0.00139	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCR2—periodontitis	0.00138	0.00138	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00137	0.00137	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—CCL2—periodontitis	0.00134	0.00134	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SLC52A3—periodontitis	0.00133	0.00133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCR2—periodontitis	0.00127	0.00127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCR2—periodontitis	0.00127	0.00127	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCR2—periodontitis	0.00126	0.00126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCR2—periodontitis	0.00125	0.00125	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00125	0.00125	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VIP—periodontitis	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00124	0.00124	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00123	0.00123	CbGpPWpGaD
Brompheniramine—CHRM2—G alpha (i) signalling events—CXCL8—periodontitis	0.00122	0.00122	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VIP—periodontitis	0.00119	0.00119	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SLC52A3—periodontitis	0.00119	0.00119	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—TNF—periodontitis	0.00118	0.00118	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL3—periodontitis	0.00116	0.00116	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL3—periodontitis	0.00116	0.00116	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL3—periodontitis	0.00116	0.00116	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL3—periodontitis	0.00115	0.00115	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCR2—periodontitis	0.00111	0.00111	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—CXCL8—periodontitis	0.00111	0.00111	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—MMP3—periodontitis	0.00111	0.00111	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SLC52A3—periodontitis	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CCR2—periodontitis	0.00109	0.00109	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CCR2—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADRB1—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SLC52A3—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CCR2—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADRB1—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADRB1—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ACP5—periodontitis	0.00108	0.00108	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CCR2—periodontitis	0.00107	0.00107	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRB1—periodontitis	0.00107	0.00107	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCR2—periodontitis	0.00106	0.00106	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—CXCL8—periodontitis	0.00106	0.00106	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—MMP3—periodontitis	0.00106	0.00106	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00106	0.00106	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR2—periodontitis	0.000987	0.000987	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000984	0.000984	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR2—periodontitis	0.000984	0.000984	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRB1—periodontitis	0.000983	0.000983	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000981	0.000981	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR2—periodontitis	0.000981	0.000981	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRB1—periodontitis	0.00098	0.00098	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000979	0.000979	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000978	0.000978	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRB1—periodontitis	0.000977	0.000977	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR2—periodontitis	0.000972	0.000972	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000969	0.000969	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRB1—periodontitis	0.000967	0.000967	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—IL6—periodontitis	0.00095	0.00095	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CCL2—periodontitis	0.000948	0.000948	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CCL2—periodontitis	0.000945	0.000945	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CCL2—periodontitis	0.000942	0.000942	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CCL2—periodontitis	0.000933	0.000933	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ACP5—periodontitis	0.000925	0.000925	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ACP5—periodontitis	0.000906	0.000906	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000873	0.000873	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR2—periodontitis	0.000862	0.000862	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRB1—periodontitis	0.000859	0.000859	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VIP—periodontitis	0.000842	0.000842	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VIP—periodontitis	0.000839	0.000839	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VIP—periodontitis	0.000836	0.000836	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VIP—periodontitis	0.000828	0.000828	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR2—periodontitis	0.000826	0.000826	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRB1—periodontitis	0.000822	0.000822	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000796	0.000796	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—IL6—periodontitis	0.000786	0.000786	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ACP5—periodontitis	0.000783	0.000783	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR2—periodontitis	0.00075	0.00075	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CXCL8—periodontitis	0.00075	0.00075	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—MMP3—periodontitis	0.000748	0.000748	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR2—periodontitis	0.000748	0.000748	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CXCL8—periodontitis	0.000747	0.000747	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000747	0.000747	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—MMP3—periodontitis	0.000746	0.000746	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR2—periodontitis	0.000745	0.000745	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CXCL8—periodontitis	0.000745	0.000745	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000744	0.000744	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—MMP3—periodontitis	0.000744	0.000744	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000742	0.000742	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR2—periodontitis	0.000738	0.000738	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CXCL8—periodontitis	0.000738	0.000738	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—MMP3—periodontitis	0.000736	0.000736	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CCL2—periodontitis	0.000719	0.000719	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000713	0.000713	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NTRK1—periodontitis	0.000703	0.000703	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.0007	0.0007	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ACP5—periodontitis	0.000699	0.000699	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CCL2—periodontitis	0.000689	0.000689	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NTRK1—periodontitis	0.000673	0.000673	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP3—periodontitis	0.000654	0.000654	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ACP5—periodontitis	0.000643	0.000643	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ACP5—periodontitis	0.000638	0.000638	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CXCL8—periodontitis	0.000626	0.000626	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP3—periodontitis	0.000626	0.000626	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000625	0.000625	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCL8—periodontitis	0.0006	0.0006	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GGT1—periodontitis	0.000598	0.000598	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR2—periodontitis	0.000583	0.000583	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR2—periodontitis	0.000581	0.000581	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB1—periodontitis	0.000581	0.000581	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR2—periodontitis	0.00058	0.00058	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB1—periodontitis	0.000579	0.000579	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB1—periodontitis	0.000577	0.000577	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR2—periodontitis	0.000574	0.000574	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB1—periodontitis	0.000571	0.000571	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00057	0.00057	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL8—periodontitis	0.000569	0.000569	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL8—periodontitis	0.000545	0.000545	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GGT1—periodontitis	0.000515	0.000515	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GGT1—periodontitis	0.000504	0.000504	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL2—periodontitis	0.000487	0.000487	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL2—periodontitis	0.000485	0.000485	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL2—periodontitis	0.000483	0.000483	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL2—periodontitis	0.000479	0.000479	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NTRK1—periodontitis	0.000476	0.000476	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NTRK1—periodontitis	0.000474	0.000474	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NTRK1—periodontitis	0.000472	0.000472	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NTRK1—periodontitis	0.000468	0.000468	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000455	0.000455	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP3—periodontitis	0.000442	0.000442	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP3—periodontitis	0.000441	0.000441	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP3—periodontitis	0.000439	0.000439	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GGT1—periodontitis	0.000436	0.000436	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP3—periodontitis	0.000435	0.000435	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PPARA—periodontitis	0.000428	0.000428	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL2—periodontitis	0.000425	0.000425	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—periodontitis	0.000424	0.000424	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—periodontitis	0.000422	0.000422	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—periodontitis	0.000421	0.000421	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ACP5—periodontitis	0.000421	0.000421	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—periodontitis	0.000417	0.000417	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL2—periodontitis	0.000407	0.000407	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000406	0.000406	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GGT1—periodontitis	0.000389	0.000389	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—periodontitis	0.000385	0.000385	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—FGF2—periodontitis	0.000384	0.000384	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—periodontitis	0.000383	0.000383	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—periodontitis	0.000382	0.000382	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—periodontitis	0.000379	0.000379	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000371	0.000371	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARA—periodontitis	0.000368	0.000368	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—FGF2—periodontitis	0.000368	0.000368	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARA—periodontitis	0.000361	0.000361	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GGT1—periodontitis	0.000358	0.000358	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GGT1—periodontitis	0.000355	0.000355	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—periodontitis	0.000336	0.000336	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—periodontitis	0.000322	0.000322	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—periodontitis	0.000319	0.000319	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARA—periodontitis	0.000312	0.000312	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—periodontitis	0.000306	0.000306	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—periodontitis	0.000304	0.000304	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—periodontitis	0.000291	0.000291	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL2—periodontitis	0.000287	0.000287	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL2—periodontitis	0.000287	0.000287	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL2—periodontitis	0.000286	0.000286	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL2—periodontitis	0.000283	0.000283	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—periodontitis	0.000278	0.000278	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARA—periodontitis	0.000278	0.000278	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGF2—periodontitis	0.00026	0.00026	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGF2—periodontitis	0.000259	0.000259	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGF2—periodontitis	0.000258	0.000258	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARA—periodontitis	0.000256	0.000256	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGF2—periodontitis	0.000256	0.000256	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARA—periodontitis	0.000254	0.000254	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—periodontitis	0.00025	0.00025	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—periodontitis	0.00024	0.00024	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—periodontitis	0.00024	0.00024	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—periodontitis	0.000235	0.000235	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GGT1—periodontitis	0.000234	0.000234	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—periodontitis	0.000227	0.000227	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—periodontitis	0.000227	0.000227	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—periodontitis	0.000226	0.000226	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—periodontitis	0.000224	0.000224	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—periodontitis	0.000216	0.000216	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—periodontitis	0.000215	0.000215	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—periodontitis	0.000215	0.000215	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—periodontitis	0.000213	0.000213	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—periodontitis	0.000206	0.000206	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—periodontitis	0.000205	0.000205	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—periodontitis	0.000204	0.000204	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—periodontitis	0.000203	0.000203	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—periodontitis	0.000202	0.000202	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—periodontitis	0.000189	0.000189	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—periodontitis	0.000181	0.000181	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—periodontitis	0.000181	0.000181	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—periodontitis	0.000169	0.000169	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—periodontitis	0.000169	0.000169	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—periodontitis	0.000168	0.000168	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARA—periodontitis	0.000167	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—periodontitis	0.000167	0.000167	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—periodontitis	0.000166	0.000166	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—periodontitis	0.000165	0.000165	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—periodontitis	0.000128	0.000128	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—periodontitis	0.000127	0.000127	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—periodontitis	0.000127	0.000127	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—periodontitis	0.000126	0.000126	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—periodontitis	0.000109	0.000109	CbGpPWpGaD
